Table 2. Patterns of allelic loss in GEJ adenocarcinomas without nuclear ß-catenin expression.
Case | A94C | C874T | Intron 4+17 G → A | G1396A | T1942C | G2063A |
---|---|---|---|---|---|---|
1 | No loss | HP | Loss | HN | Loss | HN |
2 | HN | Loss | HN | HN | Loss | HN |
3 | HN | HN | HN | Loss | Loss | HN |
4 | HN | HN | HN | HN | Loss | HN |
5 | HN | HP | HN | HN | Loss | HN |
6 | HN | HP | HN | Loss | HN | Loss |
7 | HN | No loss | HN | HN | HN | HN |
8 | No loss | HP | No loss | HN | HN | HN |
9 | HN | HN | HN | HN | HN | HN |
10 | HN | HN | HN | HN | HN | HN |
11 | Loss | HP | Loss | HN | HN | HN |
12 | Loss | Loss | HN | Loss | Loss | HN |
13 | HN | HP | HN | HN | HP | HN |
14 | HN | HN | HN | HN | HN | HN |
15 | HP | HP | HP | HN | HN | HN |
16 | No loss | HP | No loss | HN | No loss | HN |
17 | HN | Loss | HN | HN | HN | HN |
Frequency | 7/40 (18%) | 20/40 (50%) | 6/40 (15%) | 5/40 (13%) | 9/40 (23%) | 2/40 (5%) |
Frequency NP | ND | ND | ND | ND | 69/322 (21%) | 9/322 (3%) |
For abbreviations see Table 1 footnote.